The emergence of continuous glucose monitoring (CGM) over the last decade,4 5 which enables users to view real-time interstitial glucose readings and receive alarms for impending hypoglycaemia or hyperglycaemia, facilitating appropriate changes in insulin therapy, is a major step towards improved diabetes monitoring. The gene discussed is INS; the disease is Hypoglycemia.